Block listing Interim Review

RNS Number : 8829Y
GlaxoSmithKline PLC
13 May 2019
 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 13 May 2019

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan

Period of return:

From:

1 November 2018

To:

30 April 2019

Balance of unallotted securities under scheme(s) from previous return:

547,331

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

 

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

393,607

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

153,724

         

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

  

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 13 May 2019

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline Share Option Plan - Ordinary Shares

Period of return:

From:

1 November 2018

To:

30 April 2019

Balance of unallotted securities under scheme(s) from previous return:

2,223,352

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

958,344

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1,265,008

         

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 13 May 2019

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline Share Option Plan - ADS

Period of return:

From:

1 November 2018

To:

30 April 2019

Balance of unallotted securities under scheme(s) from previous return:

7,336,096

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

1,424,800

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

5,911,296

         

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 13 May 2019

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline plc Share Save Plan 2012

Period of return:

From:

1 November 2018

To:

30 April 2019

Balance of unallotted securities under scheme(s) from previous return:

5,672,623

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

3,345,727

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

2,326,896

         

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRDMGMKVFMGLZM

Companies

GSK (GSK)
UK 100

Latest directors dealings